TGase Protein Labeling Kits

ATTO-550TM TGase Protein Q-Labeling Kit



Order
Quantity
Price
Status
1 Kit 610 € available


Documents
Art. No. L106
Description ATTO-550TM TGase Protein Q-Labeling Kit is intended for MTG mediated labeling of proteins (> 5 kDa) with ATTO-550TM dye. The reagents in the kit are sufficient for labeling of 1 mg protein, either 1 x 1 mg, 2 x 500 μg or 4 x 250 μg protein per labeling reaction.
Reagents in the kit MTG - Microbial Transglutaminase
LB -  MTG-Labeling Buffer
Stop - MTG-Blocker
SQ-550 - ATTO-550TM Substrate for Q-Labeling
GPC - Purification column
Application ATTO-550TM TGase Protein Q-Labeling Kit is suitable for labeling of proteins containg accessible glutamine (Q) residues with ATTO-550TM dye.
Storage Store kit at 2 - 8°C. It is stable up to the expiry date stated on the label of the box. Do not use kit beyond its expiry date.
Store MTG at -20°C!
Note INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.
Related Products

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • imagePress release: Zedira announces ISO 9001:2015 certification

Blog  

  • DZG Aktuell: „Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227“
  • imageDesign of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
  • imageMicrobial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering

Events  

  • Gordon Research Conference: Transglutaminases in Human Disease Processes

    12.06.2022 - 17.06.2022
    Mount Snow, USA

  • 19th International Celiac Disease Symposium

    19.10.2022 - 22.10.2022
    Sorrento, Italy